1Senzaki H, Masurtani S, Kobayashi J, et al. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation, 2001,104 : 860-863.
2Takeshita S, Tokutomi T, Kawase H, et al. Elevated serum levels of matrix metalloproteinase-9(MMP-9) in Kawasaki disease. Clin Exp Immunol, 2001,125:340-344.
3Chua PK, Melish ME, Yu Q, et al. Elevated levels of metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol,2003, 10:308-314.
4Tamarina NA, McMillan WD, Shively VP, et al. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery, 1997,122:264-271.
5Orbe J, Fernandez L, Rodriguez JA, et al. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis, 2003, 170:269-276.
6Inoue T, Kato T, Takayanagi K, et al. Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome. Am J Cardiol, 2003, 92:1461-1464.
7Albisetti M, Chan AK, McCrindle BW, et al. Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease.Blood Coagul Fibrinolysis, 2003, 14 : 181-186.
8Takeshita S, Nakatani K, Kawase H, et al. The role of bacteriallipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. J Infect Dis, 1999,179:508-512.
9Gavin PJ, Crawford SE, Shulman ST, et al. Systemic arterial expression of matrix metaUoproteinases 2 and 9 in Kawasaki disease.Arterioscler Thromb Vasc Biol, 2003,23:576-581.
10Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation, 1993,87:1776-1780.
5Tsai MH, Huang YC, Yen MH, et al. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin[J]. J Pediatr, 2006,148 ( 1 ) : 38-43.
6Ran RK, Sinclair B, Newman A, et al. Recognition and management of Kawasaki disease [ J ]. CMM, 2000,162 (6) : 807-812.
7Honkanen VE, Mc Crindle BW, Laxer RM, et al. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease[ J]. Pediatr Cardiol, 2003,24 (2) : 122-126.
8Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem[J]. Pediatrics,2005,115(4) :428-433.
